Rethinking the pharma R&D lifecycle with AI in mind
Drug Discovery World
AUGUST 7, 2024
AI agents will also enable scientists to set up robotic automation just through natural language, democratising access across the industry. Advancements in AI also have the potential to address key challenges in clinical trials. Take as an example patient recruitment, the most time-consuming part of a trial.
69 
Let's personalize your content